Melanogrit potentiates melanogenesis by escalating cellular tyrosinase activity and MITF levels via pERK inhibition
Bioscience Reports · 2024
DOI: 10.1042/bsr20231324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, 2024. Verfasst von Acharya Balkrishna und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery and Development Division, Patanjali Research Foundation, NH-58, Haridwar 249405, Uttarakhand, India. Hauptthemen laut MEDLINE: Monophenol Monooxygenase, Vitiligo. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Patanjali Research Foundation Trust.
Abstract (Originalsprache)
Vitiligo is characterized by the development of white patches on the skin either due to the loss of functional melanocytes or perturbations in the melanogenesis pathway. In the present study, we investigated the therapeutic potential of herbo-mineral formulation, Melanogrit in neutralizing the white patches in the skin. The study utilized UPLC/MS-QToF technique to determine the diversified phytochemical profile in Melanogrit. The murine B16F10 cells when treated with Melanogrit underwent morphological changes, including increased angularity, enlarged cell size, and greater dendritic protrusions. To establish an equivalent model to study melanogenesis, we carefully optimized the dosage of α-melanocyte stimulating hormone (αMSH) in B16F10 cells as an alternative to using melanocyte-keratinocyte cocultures. The study determined a sub-optimal dose of αMSH (0.2 nM) in B16F10 cells that does not manifest any measurable effects on melanogenesis. In contrast, Melanogrit when used in conjunction with 0.2 nM αMSH, induced a dose-dependent increase in extracellular and intracellular melanin levels. Melanogrit transcriptionally up-regulated the decisive genes of the melanogenesis pathway, MITF, TYR, and TRP1, which was evident from the increased cellular tyrosine activity. Our findings also demonstrated that Melanogrit ameliorated the MITF protein levels by inhibiting pERK; notably without involving GSK3β in the process. Taken together, our findings strongly suggest that Melanogrit has the potential to stimulate melanogenesis, making it a promising candidate for clinical applications in the treatment of white skin patches that develop in vitiligo patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Discovery and Development Division, Patanjali Research Foundation, NH-58, Haridwar 249405, Uttarakhand, India.
- Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Roorkee-Haridwar Road, Haridwar 249405, Uttarakhand, India.
- Patanjali Yog Peeth (UK) Trust, 40 Lambhill Street, Kinning Park, Glasgow G41 1AU, U.K.
- Vedic Acharya Samaj Foundation, Inc. NFP, 21725 CR 33, Groveland, FL 34736, U.S.A.
- Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India.
ORCID-Profile: Anurag Varshney
Förderung
- Patanjali Research Foundation Trust
Zitieren
APA
Balkrishna, A., Lochab, S., Verma, S., Srivastava, J., Dev, R., & Varshney, A. (2024). Melanogrit potentiates melanogenesis by escalating cellular tyrosinase activity and MITF levels via pERK inhibition. Bioscience Reports. https://doi.org/10.1042/bsr20231324
Vancouver
Balkrishna A, Lochab S, Verma S, Srivastava J, Dev R, Varshney A. Melanogrit potentiates melanogenesis by escalating cellular tyrosinase activity and MITF levels via pERK inhibition. Bioscience Reports. 2024. doi:10.1042/bsr20231324
BibTeX
@article{Balkrishna2024,
author = {Balkrishna, Acharya and Lochab, Savita and Verma, Sudeep and Srivastava, Jyotish and Dev, Rishabh and Varshney, Anurag},
title = {Melanogrit potentiates melanogenesis by escalating cellular tyrosinase activity and MITF levels via pERK inhibition},
journal = {Bioscience Reports},
year = {2024},
doi = {10.1042/bsr20231324}
}
EUVIMED